ProMIS Neurosciences (PMN) News Today $0.95 -0.05 (-4.73%) (As of 09:46 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ProMIS Neurosciences Announces Third Quarter Financial Results and Recent HighlightsOn November 14, 2024, ProMIS Neurosciences Inc. (Nasdaq: PMN) shared its financial outcomes for the third quarter ended September 30, 2024. The company provided insigNovember 16, 2024 | americanbankingnews.comProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent HighlightsNovember 15, 2024 | finanznachrichten.deProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent HighlightsNovember 14, 2024 | globenewswire.comProMIS Neurosciences presents data from PMN310 Phase1a trialOctober 31, 2024 | markets.businessinsider.comProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer's Disease ConferenceOctober 30, 2024 | globenewswire.comProMIS Neurosciences, Inc. (NASDAQ:PMN): Among The 10 Oversold Canadian Stocks to Buy Right NowOctober 24, 2024 | finance.yahoo.comProMIS Neurosciences (NASDAQ:PMN) Stock, Insider Trading ActivityOctober 5, 2024 | benzinga.comProMIS Neurosciences (NASDAQ:PMN) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Madge K. Shafmaster Buys 60,000 SharesSeptember 25, 2024 | insidertrades.comProMIS Neurosciences Inc PMNSeptember 19, 2024 | morningstar.comProMIS Neurosciences to Showcase PMN310's Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral NeurosciencesSeptember 12, 2024 | globenewswire.comProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 5, 2024 | globenewswire.comProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $12,500.00 in StockAugust 17, 2024 | insidertrades.comProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent HighlightsAugust 8, 2024 | markets.businessinsider.comProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024August 1, 2024 | globenewswire.comProMIS Neurosciences regains NASDAQ complianceJuly 31, 2024 | uk.investing.comProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer's Association International ConferenceJuly 30, 2024 | globenewswire.comWestwood and Majesticks aiming to dig deeper as LIV Golf heads to JCB ClubJuly 26, 2024 | msn.comProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's TrialJuly 26, 2024 | globenewswire.comProMIS Neurosciences Announces Up to $122.7 Million Private Placement FinancingJuly 26, 2024 | globenewswire.comPMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q1 2024May 15, 2024 | msn.comProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent HighlightsMay 14, 2024 | globenewswire.comTrading was temporarily halted for "PMN" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 1, 2024 | marketbeat.comProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed AntibodiesApril 30, 2024 | globenewswire.comProMIS Neurosciences (PMN) Price Target Increased by 9.38% to 8.93April 17, 2024 | msn.comProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALSApril 9, 2024 | globenewswire.comProMIS Neurosciences to Present in Upcoming Investor Conferences in AprilApril 4, 2024 | globenewswire.comProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent HighlightsApril 1, 2024 | globenewswire.comProMIS Neurosciences Strengthens Global Intellectual Property PortfolioMarch 11, 2024 | globenewswire.comProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceFebruary 22, 2024 | globenewswire.comProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein VaccineJanuary 22, 2024 | finance.yahoo.comProMIS Neurosciences Inc.: ProMIS Neurosciences, Inc. Announces Leadership TransitionJanuary 3, 2024 | finanznachrichten.deBTIG Reaffirms Their Buy Rating on ProMIS Neurosciences (PMN)January 3, 2024 | markets.businessinsider.comProMIS Neurosciences Appoints Neil Warma As Interim Chief Executive OfficerJanuary 3, 2024 | markets.businessinsider.comProMIS Neurosciences, Inc. Announces Leadership TransitionJanuary 3, 2024 | finance.yahoo.comProMIS Neurosciences GAAP EPS of -$0.19 beats by $0.14November 14, 2023 | msn.comProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 6, 2023 | finance.yahoo.comProMIS Neurosciences scales 31% on $20.4M private placementAugust 22, 2023 | msn.comProMIS Neurosciences Announces $20.4 Million Private Placement FinancingAugust 21, 2023 | finance.yahoo.comTrading was temporarily halted for "PMN" at 09:07 AM with a stated reason of "LULD pause."July 27, 2023 | marketbeat.comTrading was temporarily halted for "PMN" at 09:07 AM with a stated reason of "LULD pause."July 17, 2023 | marketbeat.comTrading was temporarily halted for "PMN" at 09:07 AM with a stated reason of "LULD pause."July 17, 2023 | marketbeat.comProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsMay 15, 2023 | finance.yahoo.comClosing Bell: Promis Neurosciences Inc down on Friday (PMN)May 6, 2023 | theglobeandmail.comClosing Bell: Promis Neurosciences Inc up on Thursday (PMN)April 27, 2023 | theglobeandmail.comData Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer’s DiseaseApril 25, 2023 | finance.yahoo.comProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual MeetingApril 24, 2023 | finance.yahoo.comClosing Bell: Promis Neurosciences Inc up on Tuesday (PMN)April 19, 2023 | theglobeandmail.comClosing Bell: Promis Neurosciences Inc down on Monday (PMN)April 18, 2023 | theglobeandmail.comClosing Bell: Promis Neurosciences Inc up on Friday (PMN)April 15, 2023 | theglobeandmail.com Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW PMN Media Mentions By Week PMN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PMN News Sentiment▼0.250.46▲Average Medical News Sentiment PMN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PMN Articles This Week▼20▲PMN Articles Average Week Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Outlook Therapeutics News Cardiol Therapeutics News Repare Therapeutics News Ventyx Biosciences News Coherus BioSciences News InflaRx News Pyxis Oncology News Context Therapeutics News Avalo Therapeutics News Alto Neuroscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PMN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
